CXCL12 and neoplasm: Our in vivo study not only re-confirmed that SDFkd tumor-bearing mice survived longer than ALTS1C1 tumor-bearing mice [18], but also demonstrated that the combination of SDF-1 inhibition and RT could further prolong survival of the mice (Figure 5B).